Rapidly growing international early phase institute, with own clinics, serving international pharma, biotech & CROs.
To support early development of new drugs in patients.
To be globally recognized and valued early phase clinical service and consultancy provider.
Expand our clinical site network.
Expand the existing patients’ recruitment network.
Provide consultancy by an international team of experts